tag: Price Target Increases

MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds - Mind Medicine (NASDAQ:MNMD)

MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds – Mind Medicine (NASDAQ:MNMD)

top